Traveling Exhibit of REYATAZ(R) (atazanavir sulfate) 'Fight HIV Your Way'
Photography Contest Kicks Off in New York City
NEW YORK, April 16 /PRNewswire/ -- Broadway actress and HIV advocate
Sheryl Lee Ralph today unveiled the winning photographs of Bristol-Myers
Squibb Company's (NYSE: BMY) REYATAZ(R) (atazanavir sulfate) "Fight HIV
Your Way" Photography Contest. The contest was developed to provide
individuals whose lives have been touched by HIV with a way to express
their feelings and emotions about their personal experience with the
disease. The grand prize winning photograph and 50 second place photographs
will be showcased in a public exhibit in Vanderbilt Hall at Grand Central
Terminal in New York City from today until April 18. The exhibit will
subsequently be displayed in select cities across the U.S.
Howard Grant of Oakland, California, a retired architect and proud
father of two, submitted the grand prize winning photograph. Grant's
description of his photograph submission captures the strength he found to
overcome personal obstacles: "I felt boxed in by concepts such as 'terminal
illness,' 'damaged goods,' 'poz/neg.' The bravery and compassion of friends
liberated me to pursue new paths and passions. All I had to do was face a
new direction and step out of the box." Grant will be honored at a special
gala opening this evening.
"Each photograph in the exhibit is a piece of art that tells a thought-
provoking story about the wide variety of experiences people have with HIV
today," said original Broadway Dreamgirl Sheryl Lee Ralph, a spokesperson
for the National Minority AIDS Council who also created and produced the
HIV- inspired Broadway shows Divas Simply Singing! and Sometimes I Cry. "In
my own work as an artist and advocate, I encourage breaking the silence
around HIV, reducing the stigmas associated with HIV, and supporting the
many ways that people fight this disease each and every day. I salute the
winners of the REYATAZ 'Fight HIV Your Way' Photography Contest for the
hope and strength that their art inspires in me and others."
"Twenty years after the U.S. Food and Drug Administration approved the
first HIV treatment, Bristol-Myers Squibb created the REYATAZ Photography
Exhibition as a way for people to reflect on the advancements that allow
people today to fight HIV their way," said Anthony Hooper, president, U.S.
Pharmaceuticals, Bristol-Myers Squibb Company. "Bristol-Myers Squibb is
proud that each photograph in the exhibit provides an example of what
inspires real people to fight HIV day in and day out."
Photographs were judged based on the artists' depiction of the fight
against HIV, creativity and originality, and overall quality. The expert
panel of judges included: Vincent Laforet, Pulitzer Prize-winning
photographer; Regan Hofmann, editor-in-chief, POZ magazine; and Dwight
Powell, editor-in-chief, Clik magazine.
A total of 101 winning photographs will be published in a limited
edition hardcover book titled In Their Own Way: A Collection of Personal
Photography on Fighting HIV.
During the months of May and June, the exhibit will be displayed in
select cities including:
-- Washington, D.C.;
-- Miami Beach, Florida;
-- Venice Beach, California; and
-- San Francisco, California.
For more information on the REYATAZ "Fight HIV Your Way" Photography
Contest, please visit http://www.reyatazphotocontest.com.
REYATAZ does not cure HIV or help prevent passing HIV to others. Please
see Indication and Important Safety Information about REYATAZ on the next
page.
Important Information about REYATAZ(R) (atazanavir sulfate) 200 mg/300
mg Capsules
REYATAZ (atazanavir sulfate) is a prescription medicine used in
combination with other medicines to treat people who are infected with HIV
and has been studied in 48-week trials in both patients who have taken or
have never taken anti-HIV medicines. REYATAZ does not cure HIV or prevent
passing HIV to others.
REYATAZ should not be taken with the following medicines: ergot
medicines, Versed(R) (midazolam hydrochloride), Halcion(R) (triazolam),
Orap(R) (pimozide), Propulsid(R) (cisapride), Camptosar(R) (irinotecan
hydrochloride), Crixivan(R) (indinavir sulfate), Mevacor(R) (lovastatin),
Zocor(R) (simvastatin), rifampin, St. John's wort (Hypericum perforatum),
AcipHex(R) (rabeprazole sodium), Nexium(R) (esomeprazole magnesium),
Prevacid(R) (lansoprazole), Prilosec(R) (omeprazole), or Protonix(R)
(pantoprazole sodium). Viagra(R) (sildenafil citrate), Levitra(R)
(vardenafil HCl), Cialis(R) (tadalafil), Vfend(R) (voriconazole), Advair(R)
(fluticasone propionate and salmeterol inhalation powder), Flonase(R)
(fluticasone propionate), or Flovent(R) (fluticasone propionate) should not
be used while taking REYATAZ without first speaking with a healthcare
provider. This list of medicines is not complete. The use of all
prescription and non- prescription medicines, vitamin and herbal
supplements, or other health preparations should be discussed with a
healthcare provider.
The following side effects, symptoms, or conditions should be reported
to healthcare providers right away: a change in the way the heart beats may
occur and could be a symptom of a heart problem; diabetes and high blood
sugar may occur in patients taking protease inhibitor medicines like
REYATAZ; yellowing of the skin and/or eyes may occur due to increases in
bilirubin levels in the blood (bilirubin is made by the liver); rash
(redness and itching) sometimes occurs in patients taking REYATAZ, most
often in the first few weeks after the medicine is started, and usually
goes away within two weeks with no change in treatment; in patients with
liver disease, including hepatitis B or C, the liver disease may get worse
when taking anti-HIV medicines like REYATAZ; and some patients with
hemophilia have increased bleeding problems with protease inhibitor
medicines like REYATAZ. Kidney stones have been reported in patients taking
REYATAZ. Signs or symptoms of kidney stones include pain in your side,
blood in your urine, and pain when you urinate.
Changes in body fat have been seen in some patients taking anti-HIV
medicines. The cause and long-term effects are not known at this time.
Other side effects of REYATAZ taken with other anti-HIV medicines include:
nausea, headache, stomach pain, vomiting, diarrhea, depression, fever,
dizziness, trouble sleeping, numbness, and tingling or burning of hands or
feet. REYATAZ should be taken once daily with food (a meal or snack).
REYATAZ and other anti-HIV medicines should be taken exactly as instructed
by healthcare providers. United States Full Prescribing Information for
REYATAZ is available at http://www.REYATAZ.com.
Bristol-Myers Squibb is a global pharmaceutical and related health care
products company whose mission is to extend and enhance human life.
Visit Bristol-Myers Squibb on the World Wide Web at http://www.bms.com.
SOURCE Bristol-Myers Squibb
 back to top
Related links:
http://www.bms.com
http://www.REYATAZ.com http://www.reyatazphotocontest.com
CONTACT:
Sonia Choi, of Bristol-Myers Squibb,
+1-609-252-5132, or sonia.choi@bms.com
|
